Sign In
Buy ATHA
$6.61
+0 (+0%)
At Close: Apr 14, 2026
ATHA Energy reveals updated technical report for Angilak uranium project
09:39am, Monday, 25'th Nov 2024
ATHA Energy Corp (TSX-V:SASK, OTCQB:SASKF) has unveiled its updated 2024 technical report for its 100%-owned Angilak uranium project in Nunavut. The third-party updated technical report establishes a
Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates
04:05pm, Thursday, 07'th Nov 2024
Expects to complete healthy volunteer Phase 1 clinical study of ATH-1105 by year end and begin dosing ALS patients in 2025 Expects to complete healthy volunteer Phase 1 clinical study of ATH-1105 by y
ATHA Energy appoints seasoned experts to leadership team
09:09am, Tuesday, 29'th Oct 2024
ATHA Energy Corp (CSE:SASK, OTCQB:SASKF) has announced the appointment of Erinn Broshko as a non-executive director and Rhéal Assié as chief financial officer, starting November 6. The company said
ATHA Energy and Terra Uranium enter into strategic option agreements on key uranium projects
08:45am, Friday, 11'th Oct 2024
ATHA Energy Corp (CSE:SASK, OTCQB:SASKF) announced that it has entered into option agreement with Terra Uranium Ltd (ASX:T92) which allow the two companies to earn significant interest in each other's
ATHA Energy Announces Option Agreements With Terra Uranium for Spire, Horizon, and Pasfield Projects
07:00am, Friday, 11'th Oct 2024
VANCOUVER, British Columbia, Oct. 11, 2024 (GLOBE NEWSWIRE) -- ATHA Energy Corp. (CSE: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA”) is pleased to announce, in furtherance to its news release from Augu
ATHA Energy CEO highlights 2024 growth priorities at TD Securities Nuclear Roundtable
10:09am, Thursday, 10'th Oct 2024
ATHA Energy Corp (CSE:SASK, OTCQB:SASKF) CEO Troy Boisjoli highlighted the company's aggressive growth strategy and plans for the year ahead in a discussion at the TD Securities Annual Nuclear Fuel Cy
ATHA Energy secures entire Lac 50 structural corridor at Angilak uranium project
08:28am, Thursday, 19'th Sep 2024
ATHA Energy Corp (CSE:SASK, OTCQB:SASKF) has expanded its Angilak Project in Nunavut by acquiring the entire Lac 50 structural corridor, along with an additional prospective parallel corridor. Both co
Athira Pharma laying off 49 employees, about 70% of workforce, as part of restructuring
11:59am, Tuesday, 17'th Sep 2024
Seattle-based biotech company Athira Pharma is laying off 49 people, or about 70% of its workforce, as part of cost-cutting measures and a restructuring.
Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases
09:00am, Tuesday, 17'th Sep 2024
ATH-1105 is an orally delivered, positive modulator of the neurotrophic HGF system that is currently in a Phase 1 clinical trial with completion expected by year end 2024 and commencement of dosing of
ATHA Stock Tanks as Alzheimer's Study Fails to Meet Primary Goal
12:35pm, Wednesday, 04'th Sep 2024
Athira's phase II/III LIFT-AD study on fosgonimeton for treating mild-to-moderate Alzheimer's disease fails to meet primary and secondary endpoints.
Athira Pharma's Alzheimer's Candidate Fails To Improve Cognition And Function In Patients With Mild/Moderate Disease, Stock Sinks
08:48am, Wednesday, 04'th Sep 2024
On Wednesday, Athira Pharma, Inc. ATHA stock is trading lower after the company released topline results from its Phase 2/3 LIFT-AD clinical trial of fosgonimeton for mild-to-moderate Alzheimer's dise
Athira Pharma's Alzheimer's drug fails in mid-to-late stage trial
04:13pm, Tuesday, 03'rd Sep 2024
Athira Pharma said on Tuesday its investigative drug failed to meet the main goal in a mid-to-late stage trial in patients with mild-to-moderate Alzheimer's disease.
LIFT-AD trial did not meet primary endpoint of GST and key secondary endpoints of cognition (ADAS-Cog11) and function (ADCS-ADL23)
ATHA Energy identifies new mineralized trends at Angilak uranium project
09:47am, Tuesday, 03'rd Sep 2024
ATHA Energy Corp (CSE:SASK, OTCQB:SASKF) announced it has completed its 2024 Exploration Program at its Angilak uranium project in Nunavut, which hosts the Lac 50 uranium Deposit. The “highly succe
ATHA Energy advances exploration at Gemini and Angilak uranium projects
08:41am, Wednesday, 28'th Aug 2024
ATHA Energy Corp (CSE:SASK, OTCQB:SASKF) has provided investors with an update on its 2024 exploration programs at its uranium projects. At its Gemini project in the Athabasca Basin, Saskatchewan, the
